We are live on ! Find out more
NV

Northpond Ventures Portfolio holdings

AUM $43.7M
1-Year Est. Return 27.27%
This Fund
S&P 500
This Quarter Est. Return
-39.36%
1 Year Est. Return
-27.27%
3 Year Est. Return
-67.31%
5 Year Est. Return
10 Year Est. Return
AUM
$34.7M
AUM Growth
-$25.5M
Cap. Flow
-$2.64M
Cap. Flow %
-7.6%
Top 10 Hldgs %
100%
Holding
4
New
Increased
Reduced
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
CELL
PhenomeX Inc. Common Stock
CELL
+$2.64M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIGL
1
DELISTED
Vigil Neuroscience
VIGL
$22.7M 65.4%
4,214,498
TBIO
2
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
$10.2M 29.47%
546,896
CADL icon
3
Candel Therapeutics
CADL
$689M
$1.78M 5.13%
1,935,215
CELL
4
DELISTED
PhenomeX Inc. Common Stock
CELL
-5,390,820
Closed -$2.64M

Similar funds

Northpond Ventures's Q3 2023 Portfolio in Review

As of Q3 2023, Northpond Ventures held 4 positions worth $34.7M, down 42% from $60.2M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Northpond Ventures withdrew a net $2.64M in Q3 2023, closing 1 position. Its most notable exit was PhenomeX Inc. Common Stock, an estimated $2.64M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Northpond Ventures fully exited PhenomeX Inc. Common Stock in Q3 2023, selling an estimated $2.64M.
  • Northpond Ventures's ten largest holdings make up 100% of its $34.7M portfolio in Q3 2023.
  • Northpond Ventures opened 0 new positions and closed 1 in Q3 2023.
  • Northpond Ventures's portfolio value fell 42% quarter-over-quarter to $34.7M.

Based on Northpond Ventures's 13F filing for Q3 2023, filed 14 Nov 2023.